FDA allergy/redness relief eyedrops adverse event list includes 426 pupil dilation cases .
This article was originally published in The Tan Sheet
Executive Summary
VASOCONSTRICTOR PUPIL DILATION ADVERSE EVENT REPORTS TOTAL 426 from the first quarter of 1995 through the first quarter of 1997, according to spontaneous reporting system data compiled by the FDA Division of Pharmacovigilance & Epidemiology. The adverse drug experience reports were the basis for FDA's recent proposed OTC vasoconstrictor label statement cautioning against pupil dilation ("The Tan Sheet" March 2, p. 11).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning